Mon03182019

Robins Global News & Noticias



  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

RobinsPost News Network

+ Larger Font | + Smaller Font

Globe NewsWire News Distribution Service

Press Release: BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA


NEW YORK and IRVINE, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced today announced that Ralph Kern MD, MHSc, Chief Operating Officer and Chief Medical Officer, will provide a clinical update for the ongoing phase 3 pivotal trial of NurOwn® in ALS patients at the 9th Annual California ALS Research Summit in Irvine, California.
The California ALS Research Summit is an annual meeting of researchers, investigators, clinicians, biotech companies, government representatives, partner organizations, and advocates in ALS and related fields in California.9th Annual California ALS Research Summit Details:Date:                      Friday, January 11, 2019Time:                      2:00-2:30pm Pacific TimeLocation:                Arnold and Mabel Beckman Center of the National Academy of SciencesAgenda:                 https://sites.google.com/a/alsagoldenwest.org/california-als-research-summit/scheduleAbout NurOwn®NurOwn® (autologous MSC-NTF) cells represent a promising investigational therapeutic approach to targeting disease pathways important in neurodegenerative disorders. MSC-NTF cells are produced from autologous, bone marrow-derived mesenchymal stem cells (MSCs) that have been expanded and differentiated ex vivo. MSCs are converted into MSC-NTF cells by growing them under patented conditions that induce the cells to secrete high levels of neurotrophic factors. Autologous MSC-NTF cells can effectively deliver multiple NTFs and immunomodulatory cytokines directly to the site of damage to elicit a desired biological effect and ultimately slow or stabilize disease progression. BrainStorm is currently conducting a Phase 3 pivotal trial of autologous MSC-NTF cells for the treatment of amyotrophic lateral sclerosis (ALS). BrainStorm also recently ...


Posted: 2019-01-11 05:05:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.






Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Press Release: BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA | Globe NewsWire News Distribution Service | RobinsPost News Network - Newscast

BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA

Thu, 10 Jan 2019 22:01:00 GMT

Dr. Ralph Kern to Provide Update on the Phase 3 Pivotal Trial of Autologous MSC-NTF Cellular Therapy (NurOwn®) in ALS NEW YORK and IRVINE, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) — BrainStorm Cell ...

BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA

Thu, 10 Jan 2019 21:15:00 GMT

Dr. Ralph Kern to Provide Update on the Phase 3 Pivotal Trial of Autologous MSC-NTF Cellular Therapy (NurOwn®) in ALS NEW YORK and IRVINE, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell ...

BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA

Thu, 10 Jan 2019 21:06:00 GMT

January 11, 2019 00:05 ET | Source: BrainStorm Cell Therapeutics Inc. NEW YORK and IRVINE, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in ...

BrainStorm to Present NurOwn Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA Nasdaq:BCLI

Thu, 10 Jan 2019 17:17:00 GMT

(MENAFN - GlobeNewsWire - Nasdaq) itemprop="articleBody">NEW YORK and IRVINE, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing ...

BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA

Thu, 10 Jan 2019 16:00:00 GMT

NEW YORK and IRVINE, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating ...

Related Bing Web Search

BrainStorm to Present NurOwn® Phase 3 Study Update at the ...

(Thu, 10 Jan 2019 23:55:00 GMT)

The California ALS Research Summit is an annual meeting of researchers, investigators, clinicians, biotech companies, government representatives, partner organizations, and advocates in ALS and ...

BrainStorm to Present NurOwn® Phase 3 Study Update at the ...

(Sat, 09 Mar 2019 02:15:00 GMT)

The California ALS Research Summit is an annual meeting of researchers, investigators, clinicians, biotech companies, government representatives, partner organizations, and advocates in ALS and related fields in California.

About the Summit - California ALS Research Summit

(Thu, 28 Feb 2019 17:42:00 GMT)

The California ALS Research Summit is an annual gathering of researchers, investigators, clinicians, biotech companies, government representatives, partner organizations, and advocates in ALS and related fields.

Summit Schedule - California ALS Research Summit

(Thu, 07 Mar 2019 07:54:00 GMT)

The 9th Annual California ALS Research Summit will be held at the Arnold and Mabel Beckman Center of the National Academies of Sciences and Engineering - 100 Academy, Irvine, CA 92617. Please be sure to register in advance for the summit.

Green California Summit 2018 - UC Irvine Sustainability

(Sun, 10 Mar 2019 13:41:00 GMT)

The 12th annual Green California Summit and Expo comes to the Sacramento Convention Center April 9th and 10, 2018 at a time when California is setting the pace for environmental protection efforts worldwide.

SUMMIT 2018 – Southern California Flow Cytometry Association

(Wed, 06 Mar 2019 06:22:00 GMT)

Seventh Annual SoCal Flow SUMMIT 2018 April 9-10, Beckman Center, UC Irvine, California. The Southern California Flow Cytometry Association (SoCal Flow) brings together research, clinical and biomedical scientists from Los Angeles, Kern, San Luis Obispo, Santa Barbara, San Bernardino, Riverside, Orange County, San Diego and Imperial counties.

SoCal Flow - Southern California Flow Cytometry Association

(Wed, 13 Mar 2019 13:52:00 GMT)

Eighth Annual SoCal Flow SUMMIT 2019 Save the Date: April 29-30, Beckman Center, UC Irvine, California. The Southern California Flow Cytometry Association (SoCal Flow) brings together research, clinical and biomedical scientists from Los Angeles, Kern, San Luis Obispo, Santa Barbara, San Bernardino, Riverside, Orange County, San Diego and Imperial counties.

TRB Welcome Transportation Hazards and Security Summit ...

(Thu, 14 Mar 2019 07:03:00 GMT)

Transportation Hazards and Security Summit & Workshop 2010: Focus on Implementation Irvine, California 23-26 August 2010. TRB Mission Statement. To provide leadership in transportation innovation and progress through research and information exchange, conducted within a setting that is objective, interdisciplinary,

Program – California Hydrogen Business Council

(Fri, 15 Mar 2019 12:24:00 GMT)

California is making enormous investments to electrify its energy and transportation sectors. The hydrogen industry will need to work with the legislative and regulatory bodies to achieve hydrogen’s appropriate role among the alternative energy options.

Related News Story Videos From Youtube

Claudia Kawas - Preventing Alzheimer's Disease: What We've Learned from the Oldest Old


Related Videos On: Claudia Kawas - Preventing Alzheimer's Disease: What We've Learned from the Oldest Old


Dementia and Down Syndrome - Ira T. Lott, MD


Related Videos On: Dementia and Down Syndrome - Ira T. Lott, MD


Cordula Dick-Muehlke - MCI Panel: Living with Cognitive Impairment


Related Videos On: Cordula Dick-Muehlke - MCI Panel: Living with Cognitive Impairment


Mohnish Pabrai Lecture at Univ. of California, Irvine (UCI), May 24, 2016


Related Videos On: Mohnish Pabrai Lecture at Univ. of California, Irvine (UCI), May 24, 2016


Ken Kosik - Clinical Trials: What We've Learned from Colombian Families


Related Videos On: Ken Kosik - Clinical Trials: What We've Learned from Colombian Families






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2019 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.